Iovance Biotherapeutics Inc (IOVA)
3.78
+0.00%
Iovance Biotherapeutics Inc (IOVA) is currently trading at $3.78. This represents a gain of 0% from the previous session. With a market capitalization of $1.50B, IOVA is a key component of the Health Care sector. Investors looking to trade IOVA should compare margin rates and options platforms to optimize their portfolio management.
Broker Promotion
Get 15 Free Stocks on Moomoo →
T&Cs Apply. Trade IOVA commission-free.
Trading Platform Comparison
Moomoo
- Min Deposit: $0
- Commissions: $0
- Fractional Shares: ✅
- Options: ✅
- Notes: Good for small traders
IBKR
- Min Deposit: $0
- Commissions: $0–$0.005/share
- Fractional Shares: ✅
- Options: ✅
- Notes: Professional-level tools
Ameritrade
- Min Deposit: $0
- Commissions: $0
- Fractional Shares: ✅
- Options: ✅
- Notes: Strong research tools
Webull
- Min Deposit: $0
- Commissions: $0
- Fractional Shares: ✅
- Options: ✅
- Notes: Easy mobile app
AI Market Sentiment
As of today, Iovance Biotherapeutics Inc (IOVA) shows a bullish trend. Analysts are watching the 0.00 level closely.
Fundamentals
Mkt Cap1.50B
P/E Ratio0.0000
Volume1,489,938
60-Day Technical Chart
Advanced Charting
Need more indicators for IOVA? Use the world's #1 platform.
Open IOVA on TradingView →Charting Platforms
TradingView
Advanced charts & indicators, web & mobile
StockCharts
Technical analysis charts with overlays & indicators
BarCharts
Market data, charts, and technical signals
Finviz
Visual stock charts & heatmaps
Yahoo Finance Charts
Basic interactive charts with indicators
Side-by-Side: Stocks Near $4
| Metric |
IOVA +0.00% |
RXRX +0.00% |
BATL +0.00% |
BBAI +0.00% |
|---|---|---|---|---|
| Price | $3.78 | $3.53 | $4.08 | $3.90 |
| Mkt Cap | $1.50B | $1.84B | $0.07B | $1.70B |
| - | View → | View → | View → |
Latest Headlines
After IOVA Stock’s Best Day In 2 Years, Analyst Sees Over 300% Upside: Here’s Why
Stocktwits • Feb 25, 2026
1 Nearly Unknown Biotech Stock Set To Go Parabolic If Its Pipeline Hits
The Motley Fool • Feb 23, 2026
IOVA Stock Upgraded to Market Outperform by Citizens Analyst | I
GuruFocus • Feb 25, 2026
One-time cell therapy shrinks tough sarcomas in early Iovance trial
Stock Titan • Feb 24, 2026
Iovance (IOVA) Shares New Amtagvi Data, Analysts Stay Positive
Yahoo Finance • Feb 23, 2026
● Gemini Agentic AI Analyst Insight for IOVA
Market Education
- 10 rules of money - Follow this and you are set for life Jul 16, 2023
- Money manifesting videos - POS and used by Nutcases Jul 16, 2023
- Stocks with Cash and Low Debt Dec 10, 2023
External Research